Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
A different scope from Chemical Profiles, which picks out a specific, pre-chosen family of compounds (a phytochemistry-style approach). This section is for full metabolomics: an unbiased sweep of every metabolite detectable in a sample at once, meant to surface biochemical activity and pathway-level behavior that a narrowly targeted compound list would miss. This section provides real matched experimental-metabolomics studies (MetaboLights) and real genome-based metabolic-pathway inference (KEGG) for species with a genome already in this catalog — KEGG rows reflect which pathways a species' own annotated genes place it in, not experimentally measured metabolite presence, stated explicitly on every such row below.
Have data of this kind? How to contribute data →
MetaboLights: Diversity in DNA: Identification of methylated deoxyadenosines in higher eukaryotes (View at source ↗)
KEGG: KEGG genome-based metabolic profile (xla) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presenceAFDSI-METABPROF-19